Made from the Haschberg-variety, the finest elderberries in the world, each serving is equal to 80 berries and also contains 11 mg of Zinc and 5 billion CFU of Bacillus subtilis DE111® Probiotic.

VENICE, Fla. (PRWEB)
June 17, 2020

Enzymedica®, a Florida-based company that produces high quality natural digestive products, announced today the launch of its newest immunity support supplement – Black Elderberry Plus Probiotics and Zinc On-The-Go Immune Packs. * The convenient, delicious quick-melt is sugar free and can be placed on the tongue or sprinkled on a favorite food. Made from the Haschberg-variety, the finest elderberries in the world, each serving is equal to 80 berries and also contains 11 mg of Zinc and 5 billion CFU of Bacillus subtilis DE111® Probiotic.

Zinc has been shown in clinical studies to help the body make protein and DNA, while the primary mechanism of action for its immune support impact is its influence on the RNA replication of invaders. * In addition, the Probiotic DE111 is a clinically studied strain of Bacillus subtilis that delivers digestive and immune health benefits. *

However, the star of Enzymedica’s new immune health supplement is the ElderCraft® European Black Elderberry Extract from Austria. Naturally rich in anthocyanins, polysaccharides and berry micronutrients, the ElderCraft® extract has been clinically studied for its natural effects on the immune system. * It is made using an exclusive technology that treats fruits gently without using any harsh solvents. The solvent-free, extraction process allows the phytonutrient integrity of the berry to be maintained. As a result, ElderCraft® supports immune health in the following ways:

●    Provides support for overall immune health. *

●    Supportive supplement for sinus and upper respiratory tract health. *

●    Immune defense during times of stress. *

●    Throat and chest supplement. *

●    Helps soothe a scratchy throat. *

The new Black Elderberry Plus Probiotics and Zinc On-The-Go Immune Packs are $19.99 for 15 powder packs and can be purchased at https://enzymedica.com/products/black-elderberry-plus-probiotics-zinc?variant=32085269184561. It contains 425mg of ElderCraft European Black Elderberry in each serving and is free from gluten, milk, casein, soy, egg, and artificial colors or flavors. It can be paired with Enzymedica’s Enzyme Defense for added support. *

About Enzymedica

Florida-based Enzymedica is a leading natural digestive health company since 1998 and sells to over 30,000 stores worldwide and online. Its top-selling enzyme brand is No. 1 in America. The company has received more than 50 industry awards including multiple Better Nutrition Magazine’s People’s Choice Awards, many Best of Supplements Awards and numerous VITY and Nexty Awards. Visit https://enzymedica.com/ for more information.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent disease.

Media Contact:

Ria Romano, Partner

RPR Public Relations, Inc.

Tel. 786-290-6413-

Share article on social media or email:

As we continue to face the COVID-19 crisis to varying degrees, payers need to proactively intervene with those who have co-related chronic diseases, including those with asthma, CHF, COPD, and diabetes to manage future medical costs and ensure their long-term health and well-being.

TULSA, Okla. (PRWEB)
June 17, 2020

Healthcare data curation and enrichment company Verinovum announced today it is offering free data assessments to help payers analyze the quality and completeness of their patient clinical data necessary to identify and provide care for specific chronic disease states that render their members vulnerable to COVID-19.

“In the aftermath of the initial COVID-19 pandemic, payers are now asking how they can more accurately identify their most at-risk populations. And many have found it’s only by integrating, cleansing and enriching clinical data that they can finally connect the dots and serve their most vulnerable chronically ill members,” says Verinovum CEO Mark McCurry. “As we continue to face the COVID-19 crisis to varying degrees, payers need to proactively intervene with those who have co-related chronic diseases, including those with asthma, CHF, COPD, and diabetes to manage future medical costs and ensure their long-term health and well-being.”

Verinovum’s COVID-19 related chronic condition data assessment helps payers assess the quality of their clinical data for these specific conditions and pinpoint exactly which data elements are needed for each member cohort. The assessment involves two phases: within 60 days of receiving raw clinical data, Verinovum delivers a high-level report identifying gaps in overall data completeness. Then, 30 days thereafter, Verinovum highlights areas where significant data enrichment improvements are possible for specific chronic disease use cases such as asthma or diabetes, including medications, diagnosis, procedures, lab results, vital signs, and more.

Due to the urgency and gravity of the pandemic, the assessment is being made available to payers at no cost as part of Verinovum’s ongoing commitment to helping healthcare organizations combat COVID-19.

As an example of how Verinovum helps improve data quality, in a recent engagement with a major national health plan, only 14% of the raw clinical data had the proper structure and requisite data elements to support advanced clinical and analytical use cases. After Verinovum curated and enriched the data, more than 89% was usable, directly impacting patient outcomes and dramatically improving data integrity for use with downstream applications.

“I’ve seen firsthand the lack of clean, complete clinical outcomes data that payers need to impact care at the population level,” says Kelley Smith, RN, MPH. “Finally, there’s a methodology available to extract, clean and enrich these critical data elements. It’s more important than ever, with the severity of COVID-19 being correlated with certain co-morbidities, that payers have the tools necessary to identify chronic conditions and pre-empt adverse events whenever possible.”    

About Verinovum

Verinovum is a market leader in clinical data curation and enrichment, enabling payers, providers, clinically integrated networks, and accountable care organizations to improve operating performance and quality with actionable information. By delivering clean, complete, and accurate data, Verinovum supports healthcare organizations in their efforts to access the right information, in the right format, at the right time, so it may be tailored and curated to fulfill specific use cases and achieve mission-critical clinical and business goals. Discover more at Verinovum.com.

Share article on social media or email:

“Having an established neighbor in a growing European market helps pave an easier path for the hemp farmer,” says Mike Leago, COO of High Grade. “This expansion will encourage European hemp cultivators to try new varietals, better diversify their crops, and increase profitability.“

LONGMONT, Colo. (PRWEB)
June 17, 2020

High Grade Hemp Seed is answering the demand for best-in-class hemp cultivars in Europe with a powerful new distribution partnership, making High Grade’s entire catalog available internationally. This is the first of many steps toward streamlining full international distribution, and opens up the European market in a way that was previously difficult to navigate. It also ensures faster access, facilitating easier processing and rapid shipping timelines within the European Union, as well as providing access to previously difficult to obtain best-in-class hemp genetics.

All High Grade Hemp Seed strains are now available for sale as seeds in Europe.

“Amidst the turmoil in import/export regulations and the ever-changing political landscape, having an established neighbor in a growing European market helps pave an easier path for the hemp farmer,” says Mike Leago, COO of High Grade. “It takes strong relationships built on trust and transparency to create a partnership that is effective across the ocean. We have that faith in Swiss Cannabinoid to stand beside us as we help elevate seed genetics worldwide. This expansion will encourage European hemp cultivators to try new varietals, better diversify their crops, and increase profitability.“

High Grade Hemp Seed and Swiss Cannabinoid launched its official collaboration earlier this year by paving the way in CBG production in the U.S. with the release of its highly popular new strain, Matterhorn CBG. This international distribution agreement builds upon that partnership, making the entire High Grade portfolio of proven hemp genetics available to European buyers.

Matthias Ghidossi, founder of Swiss Cannabinoid, has been a key player in the European hemp industry for years. Of the High Grade partnership, Ghidossi shared, “After kick-starting a highly synergistic relationship with the High Grade team on Matterhorn, becoming their European distribution partners was a natural progression. As one of the largest and most respected hemp genetics companies in the world, this fresh infusion of hemp cultivars into the European market will be a great benefit to farmers across the EU.”

Isaac Cohen, Chief Financial Officer at High Grade Hemp Seed, stated, “Our team has successfully navigated regulatory hurdles, distribution and fulfillment complexity, and customer service considerations to build a robust distribution ecosystem capable of selling and shipping our hemp cultivars to farmers throughout Europe. This has been a huge endeavor, and I’m immensely proud of our team for getting the job done in time for 2020 planting.”

Looking ahead to 2021 and beyond, High Grade is pushing R&D with 20 new terpene crosses and leading edge genetics focused on high-potential minor cannabinoids. The company’s mission continues to center on the needs of farmers, delivering the best genetics and superior results to power their success.

For the full list and background on High Grade’s best-in-class varietals, visit HighGradeHempSeed.com . For Europe orders, visit https://swisscannabinoid.ch/.

About High Grade Hemp Seed

HGH Seed, Inc., is a Colorado-based hemp genetics company committed to farming top-quality, consistent strains of hemp. High Grade has been pivotal in the reintroduction of industrial hemp to the global supply chain. CEO Bodhi Urban and the High Grade team introduced foundational strains such as Cherry Wine and Berry Blossom that are the basis of hemp genetics today. The company is known for its proven track record of compliance, high feminization and germination rates, and high cannabinoid levels. To learn more about High Grade, or to inquire about purchasing seeds, visit highgradehempseed.com.

About Swiss Cannabinoid

Swiss Cannabinoid is a pioneering company focused on research and development for new genetics of Cannabis Sativa l. In the past several years, the company has been pivotal in the development of new strain lines with low THC content. Today Swiss Cannabinoid collaborates with pharmaceutical companies and key players in the cannabis industry, ranging from North America to Eastern Europe. They are also extending their role across the supply chain and are a key distributor for High Grade in Europe. To learn more, visit swisscannabinoid.ch.

Share article on social media or email:

Diagram showing levels of neutrophil immune cells (red dots) in a healthy donor, a patient with moderate COVID-19 and a patient with severe COVID-19

“Identifying patients who are trending toward a cellular crisis and then implementing early, appropriate treatment could improve mortality rates for severe COVID-19 patients,” said Jun Yan, M.D., Ph.D.

LOUISVILLE, Ky. (PRWEB)
June 17, 2020

Jun Yan, M.D., Ph.D., professor of surgery and microbiology and immunology at the University of Louisville, led a team of researchers in the discovery of an important biomarker that predicts a crisis in COVID-19 patients that could lead to death.

Yan, an immunologist and researcher with the UofL Health – James Graham Brown Cancer Center, along with UofL Professor of Anesthesiology Jiapeng Huang, M.D., Ph.D., and M.D./Ph.D. student Samantha Morrissey, Ph.D., conducted a patient study to better understand the most severe cases of COVID-19.

Approximately 20 percent of COVID-19 patients experience severe disease, including pneumonia and acute respiratory distress syndrome (ARDS). In some of these patients, the rapid influx of immune cells to the lungs to fight the infection leads to complications in the lung and blood coagulation disorders, resulting in heart attack, pulmonary embolism, stroke or deep vein thrombosis.

To better understand these serious complications, Yan’s team evaluated levels of various immune cells in blood samples of COVID-19 patients and compared those levels with those of healthy individuals. They discovered that one type of immune cells, low-density inflammatory neutrophils, became highly elevated in some patients whose condition became very severe. This elevation signaled a point of clinical crisis and increased likelihood of death within a few days.

Neutrophils are one type of immune cells that serve as the first line of defense in the body. When an individual acquires an infection, neutrophils rush to the site to clear the pathogen causing the infection. However, if their presence is persistent or there is a very high volume of cells at the site of infection, in this case the lungs, they can cause unwanted adverse effects. In the case of patients with severe COVID-19, a blood clotting disorder known as coagulopathy occurred, that can manifest as pulmonary embolism, heart attack or stroke.

The study, published online as a preprint, details shifting levels of these neutrophils and other immune cells through repeated blood samples from study participants, correlated with improvement or worsening of the patients’ condition. If clinicians could detect a rise in these cells, they may be able to provide therapy to prevent the potential life-threatening conditions associated with them.

“Based on this study, we believe that the low-density inflammatory band neutrophil population contributes to COVID-19-associated coagulopathy (CAC) and could be used as a clinical marker to monitor disease status and progression,” Yan said. “Identifying patients who are trending toward a cellular crisis and then implementing early, appropriate treatment could improve mortality rates for severe COVID-19 patients.”

To provide additional clinical options for physicians in addressing these crises, Yan is now working with other researchers at UofL to test potential therapies.

Share article on social media or email:

The Barnes Firm coronavirus lawyers are representing and helping families who have been wrongfully exposed to the COVID-19 virus.

“Even given all the shelter-in-place orders, you really can’t wait when it comes to contacting a lawyer. Also, getting medical treatment can be a great hurdle for our clients and we are here to assist,” said Landon Vivian, injury attorney for The Barnes Firm in the Bay Area.

SAN FRANCISCO (PRWEB)
June 17, 2020

On ABC 7 News in the San Francisco Bay Area, one of The Barnes Firm’s best injury lawyers, Landon Vivian, explained how they’ve adapted to working through COVID-19 to protect client interests. The Barnes Firm coronavirus lawyers are representing and helping families who have been wrongfully exposed to the COVID-19 virus.

Many people who may have been exposed to COVID-19 in nursing homes, senior care centers, prisons, holding centers, and many other facilities have reached out to The Barnes Firm. Their COVID-19 lawyers are focusing on what was done and what could have been done reasonably to prevent that exposure from occurring, and that is a major focal point as they advance in these cases.

The Barnes Firm injury attorneys are here to answer any questions for family members who have lost a loved one to the Coronavirus:

• Who’s responsible?
• What can be done?
• Why wasn’t my family protected from COVID-19?

Each county in California has different rules in place and The Barnes Firm will look to show where their client came into contact with the person who exposed them to COVID-19. Attorney Vivian mentions that each case is unique and it is important to gather all facts and conduct a proper investigation.

Attorney Landon Vivian advises not to wait when it comes to contacting a lawyer to advocate for your rights. They can also help with getting medical treatment to decrease disruption to cases.

“Even given all the shelter-in-place orders, you really can’t wait when it comes to contacting a lawyer. Also, getting medical treatment can be a great hurdle for our clients and we are here to assist,” said Landon Vivian, injury attorney for The Barnes Firm in the Bay Area.

Family members who’ve been wrongfully exposed to the coronavirus in nursing homes, senior care centers, holding centers, and other facilities can contact the experienced team at The Barnes Firm to help get the answers to their legal questions. For more information, please visit The Barnes Firm website.

About The Barnes Firm:

The Barnes Firm’s experienced personal injury attorneys focus exclusively on accident cases. They have helped thousands of injured victims get the best results possible with their settlements and verdicts.

The firm helps families across California, and has offices located in Los Angeles, Oakland, and San Diego.

In addition to legal services, The Barnes Firm stays involved in the community through its ongoing local philanthropy efforts. The California car accident lawyers sponsor academic organizations and nonprofits throughout the state. For more information, please visit https://www.thebarnesfirmcommunity.com/.

If you’ve been in an accident, you can count on The Barnes Firm Injury Attorneys to help. Please visit https://www.thebarnesfirm.com/. You can also find The Barnes Firm on Facebook, Instagram, Twitter, and LinkedIn.

Share article on social media or email:

SimpliFed logo: SimpliFed launches their services as the first independent tele-lactation consulting and nutrition support platform.

“I have been deeply troubled by the lack of support available for moms following births during COVID-19, which led to the founding of this new platform for moms seeking lactation and infant nutrition guidance,” said Andrea Ippolito, founder of SimpliFed.

ITHACA, N.Y. (PRWEB)
June 17, 2020

SimpliFed, the first independent telehealth platform exclusively focused on infant feeding and nutrition, announced today that it has officially launched its services to help new parents navigate how best to feed their new baby in the comfort and safety of their own homes. The new platform launches amid social distancing measures, which impacts the practice of in-home lactation and infant nutrition guidance. SimpliFed was founded by a Cornell University faculty member and new mom in collaboration with her own lactation consultant. The mission of the platform is to empower each parent to make an educated decision to choose what works best for them and their baby whether that be breastmilk, infant formula, or a combination of both.

“I have been deeply troubled by the lack of support available for moms following births during COVID-19, which led to the founding of this new platform for moms seeking lactation and infant nutrition guidance,” said Andrea Ippolito, founder of SimpliFed. “We want to relieve moms of some of the stress in those first few days and weeks while they are home with their infant by helping them secure the lactation and nutrition support necessary for a healthy baby.”

Ippolito, who is also a Cornell University faculty member, committed to founding SimpliFed after reflecting on her own experience as a new mom facing breastfeeding challenges. When she was first home with her own child, she was able to easily work with lactation consultants, who typically provide care for new moms either in pediatric offices or via in-home care. More recently however, Ippolito realized that during a crisis such as COVID-19 and social distancing, most new mothers do not have the luxury of that experience. Ippolito was able to leverage insights that she gained during her Master’s program at MIT as she studied telehealth in the United States military and Department of Veterans Affairs, both of which were early adopters of telehealth.

SimpliFed provides telehealth access to board-certified lactation consultants (IBCLCs) to help new mothers navigate the various infant feeding options available to ultimately make the best personal choice. Lactation consultant appointments are booked with initial fees beginning at $30 for 20 minutes, with follow up appointments added as necessary by the mother. Reimbursement is often covered by the parents’ health insurer or their HSA/FSA program. Through the Affordable Care Act, all new health plans must cover both comprehensive prenatal and postnatal lactation support and counseling. Thus, breastfeeding mothers have coverage for lactation counseling without cost-sharing for as long as they are breastfeeding.

“Building on what we’ve learned so far, we continue to co-design and improve SimpliFed with the help and feedback of moms to meet the needs of new moms,” said Ippolito. “By remotely connecting lactation consultants to new mothers, SimpliFed is the next best thing to having a lactation consultant come to your home. We want to empower each parent to help them understand the best option available for them, to ultimately help them reach their baby’s feeding goals for their long-term health.”

More information about SimpliFed can be found: https://www.simplifed.us/.

ABOUT SIMPLIFED

SimpliFed is the first independent tele-lactation consulting and nutrition support platform connecting new mothers with resources in the first weeks of becoming a parent. The company’s mission is to help new mothers secure access to breastfeeding and infant nutrition support from the comfort and safety of their own homes from board-certified lactation consultants (IBCLCs). Founded by Andrea Ippolito, a Cornell University faculty member, who struggled with breastfeeding her own child, found the resources to decide what feeding options worked best for her and her baby, and realized that more mothers need access to lactation care, especially during times of crisis. The SimpliFed platform is accessible to new moms across the US, with lactation consultants available for appointment at the parents’ convenience. More information can be found at: https://www.simplifed.us/

Share article on social media or email: